BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2003) 76, 674-677
© 2003 British Institute of Radiology
doi: 10.1259/bjr/62523154

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dendy, P P
Right arrow Articles by Brugmans, M J P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dendy, P P
Right arrow Articles by Brugmans, M J P

Low dose radiation risks

P P Dendy, PhD1 and M J P Brugmans, PhD2

1 Regional Radiation Protection Service, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, UK and 2 National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands



View larger version (7K):

[in a new window]
 
Figure 1. Schematic representation of the two-mutation model for cancer induction. The organ of interest is assumed to contain N normal cells that have the potency to become malignant (M) in two rate-limiting steps (stochastic rates µ1 and µ2). In the intermediate stage (I), the growth advantage of cells on the pathway to malignancy is accounted for by stochastic birth and death rates ({alpha} and {beta}, respectively). The growth time of a malignant cell into a detectable tumour (T) is characterized by a deterministic lag time (tlag).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2003 by the British Institute of Radiology.